The $20 million will be used to accelerate three ongoing clinical trials by the company for Covid-19 vaccines and cancer treatments. In January, GeoVax raised $10 million for the same clinical trials.
The $20 million will be used to accelerate three ongoing clinical trials by the company for Covid-19 vaccines and cancer treatments. In January, GeoVax raised $10 million for the same clinical trials.
